Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease.

about

Trends and patterns of analgesic prescribing in Malaysian public hospitals from 2010 to 2016: tramadol predominately used

P2860

Q57072064-A5C408E8-7162-4369-9946-77B82B96CBAB

P2860

Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease.

Item

http://www.wikidata.org/entity/Q38990657

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cardiovascular Safety and Blee ...... s with Cardiovascular Disease.

@en

type

Item

label

Cardiovascular Safety and Blee ...... s with Cardiovascular Disease.

@en

prefLabel

Cardiovascular Safety and Blee ...... s with Cardiovascular Disease.

@en

P1476

Cardiovascular Safety and Blee ...... s with Cardiovascular Disease.

@en

P2093

Anthony A Bavry

http://www.w3.org/2001/XMLSchema#string

Steven J Ross

http://www.w3.org/2001/XMLSchema#string

P2860

Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis

Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group

Aspirin and coumadin after acute coronary syndromes (the ASPECT-2 study): a randomised controlled trial

Effect of ibuprofen on cardioprotective effect of aspirin

Cardiovascular and cerebrovascular events in the randomized, controlled Alzheimer's Disease Anti-Inflammatory Prevention Trial (ADAPT)

Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial

Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial

P2888

s11886-017-0814-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S11886-017-0814-5

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Islam Y. Elgendy

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083395796

http://www.w3.org/2001/XMLSchema#string

P698

28138824

http://www.w3.org/2001/XMLSchema#string

Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease.

about

P2860

P2860

Cardiovascular Safety and Bleeding Risk Associated with Nonsteroidal Anti-Inflammatory Medications in Patients with Cardiovascular Disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698